Virax Biolabs Group Stock (NASDAQ: VRAX) stock price, news, charts, stock research, profile.
Open | $2.50 |
Close | $2.44 |
Volume / Avg. | 554.53K / 4.48M |
Day Range | $2.43 - $2.56 |
52 Wk Range | 0.60 - 9.00 |
Market Cap | $10.51M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 15.6% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Virax Biolabs Group (NASDAQ:VRAX) through any online brokerage.
Other companies in Virax Biolabs Group’s space includes: Akso Health (NASDAQ:AHG), McKesson (NYSE:MCK), Henry Schein (NASDAQ:HSIC), Patterson Cos (NASDAQ:PDCO) and Cencora (NYSE:COR).
There is no analysis for Virax Biolabs Group to provide a consensus price target.
The stock price for Virax Biolabs Group (NASDAQ: VRAX) is $2.4201 last updated September 20, 2024 at 7:45 PM EDT.
There are no upcoming dividends for Virax Biolabs Group.
Virax Biolabs Group’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Virax Biolabs Group.
Virax Biolabs Group is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.